Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Brett Favre tells Congress he's been diagnosed with Parkinson's
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
FTC sues drug middlemen for allegedly inflating insulin prices
Pesky medical bill? Most people don't take a key step to manage that debt, study finds
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
